Topic · page 3 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 81–120 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

Semin Arthritis Rheum4 Jun 2026
Structural damage assessment in the spine of patients with axial spondyloarthritis – results from an international OMERACT multi-reader exercise using MRI-based synthetic CT
Diagnostic or prognostic study
Semin Arthritis Rheum3 Jun 2026
The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint–gut remission: Four-year outcomes from the real-world SPIB cohort
Cohort study
J Rheumatol1 Jun 2026
Introducing the Global Exploration of Psoriatic Arthritis Disease Activity Assessment (EXPLORE-PsA): The First Young-GRAPPA Research Initiative
Cross-sectional study
Rheumatology (Oxford)29 May 2026
Cycling versus swapping strategies for treatment of psoriatic arthritis after primary tumour necrosis factor inhibitors failure: a systematic review and meta-analysis
Meta-analysis
Arthritis Res Ther28 May 2026
Circulating immune cell biomarkers in Psoriatic Arthritis: associations with clinical manifestations and treatment response in the TOFA-PREDICT trial
Secondary analysis
Ann Rheum Dis27 May 2026
Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritis
Secondary analysis
Joint Bone Spine26 May 2026
Two patterns of sacroiliac joint bone marrow oedema are apparent in AxSpA determined by HLA-B27 status, body mass index or psoriasis
Cross-sectional study
RMD Open21 May 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitis
Randomized controlled trial
Rheumatology (Oxford)19 May 2026
Repair of radiographic joint damage in psoriatic arthritis: a cohort study
Cohort study
Arthritis Care Res (Hoboken)16 May 2026
Associations of Lifestyle‐Related Factors and Psoriatic Arthritis Disease Activity: The Dutch South West Psoriatic Arthritis Study
Cohort study
RMD Open13 May 2026
Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extension
Meta-analysis
Ann Rheum Dis13 May 2026
Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment
Meta-analysis
RMD Open11 May 2026
Ultrasound assessment of vertebral ligaments: development and validation of a landmark-based scanning protocol with potential applicability in spondyloarthritis
Diagnostic or prognostic study
Arthritis Rheumatol11 May 2026
Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study
Randomized controlled trial
Rheumatology (Oxford)9 May 2026
Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis
Cohort study
RMD Open7 May 2026
Impact of biologic class and treatment line on psoriatic arthritis risk in psoriasis: a population-based cohort study
Cohort study
RMD Open7 May 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis
Cohort study
Lancet Rheumatol6 May 2026
Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study
Cross-sectional study
J Rheumatol1 May 2026
Epidemiological Characteristics of Psoriatic Disease in Peru From 2016 to 2023
Secondary analysis
J Rheumatol1 May 2026
Regional Trends and Patterns of Axial Spondyloarthritis in Latin America: A Study from the ESPALDA Registry (2019–2024)
Cross-sectional study
Scand J Rheumatol1 May 2026
Annual trends of chronic opioid use in patients with inflammatory bowel disease and spondyloarthritis in Denmark between 2000 and 2023
Cohort study
JAMA Netw Open1 May 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial
Randomized controlled trial
RMD Open29 Apr 2026
Development and validation of a new ultrasound score (SONAR-7) for synovitis in psoriatic arthritis and axial spondyloarthritis
Diagnostic or prognostic study
Arthritis Rheumatol27 Apr 2026
Determinants of Difficult‐to‐Manage and Treatment‐Refractory Axial Spondyloarthritis: A Cross‐Sectional Analysis Within a Longitudinal Cohort
Cross-sectional study
Arthritis Rheumatol27 Apr 2026
Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts
Cohort study
Arthritis Res Ther25 Apr 2026
Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab
Cohort study
Rheumatology (Oxford)25 Apr 2026
Clinical outcomes in psoriatic arthritis patients with rheumatoid factor positivity
Cohort study
Arthritis Res Ther22 Apr 2026
Insights into axial spondyloarthritis features and the development of imaging evidence of sacroiliitis during long-term follow-up in routine clinical practice
Cohort study
Rheumatology (Oxford)22 Apr 2026
Bacterial translocation and intestinal permeability in early axial spondyloarthritis association with 5-year outcomes: insights from the DESIR cohort
Cohort study
Arthritis Rheumatol22 Apr 2026
Functional Impact of Structural Damage in Psoriatic Arthritis: Insights from a Prospective Cohort Study
Cohort study
Arthritis Rheumatol21 Apr 2026
High‐Resolution Deep Learning Dixon Magnetic Resonance Imaging of the Sacroiliac Joints Is Noninferior to Standard Magnetic Resonance Imaging in Patients With Suspected Axial Spondyloarthritis
Diagnostic or prognostic study
Semin Arthritis Rheum19 Apr 2026
Epicardial fat as a cardiovascular risk factor in inflammatory arthritis
Cross-sectional study
Rheumatology (Oxford)17 Apr 2026
Phenotypic differences and treatment persistence in a large multicentre cohort of axial psoriatic arthritis
Cohort study
Arthritis Rheumatol16 Apr 2026
Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study
Randomized controlled trial
Rheumatology (Oxford)15 Apr 2026
Transcriptomic profiling of secukinumab-treated psoriatic arthritis reveals potential novel response-associated pathways
Mechanistic study
Rheumatology (Oxford)15 Apr 2026
Development of structural damage in the spine in patients with PsA: findings from a longitudinal cohort study
Cohort study
RMD Open13 Apr 2026
Renal involvement in ankylosing spondylitis: a retrospective, population-based cohort study using data from the TriNetX Global Network
Cohort study
Ann Rheum Dis11 Apr 2026
Psoriatic arthritis monocyte DNA methylomes bridge joint and skin inflammatory pathways across rheumatoid arthritis and psoriasis
Mechanistic study
Joint Bone Spine11 Apr 2026
Preconception, pregnancy and postpartum periods in spondyloarthritis: Unmet needs and challenges from a patients and rheumatologists surveys
Cross-sectional study
Arthritis Res Ther11 Apr 2026
No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials
Meta-analysis

All 1,039 Briefs in ExploreShowing Briefs 81–120 of 1,039, newest first